TARGIT™ technology: Coated starch capsules for site-specific drug delivery into the lower gastrointestinal tract

Expert Opinion on Drug Delivery

Volumn 2, Issue 1, 2005, Pages 159-167

  Watts, Peter ^a   Smith, Alan ^b  

^a Albert Einstein Centre   (United Kingdom)

^b NONE

Author keywords

Colon; pH sensitive coating; Site specific; Starch capsule

Indexed keywords

AMINOSALICYLIC ACID; AMYLOSE; ANTIBIOTIC AGENT; BALSALAZIDE; BUDESONIDE; CELLACEFATE; CHLORPROMAZINE; CORTICOSTEROID; DIAZEPAM; DICLOFENAC; ERGOTAMINE; ETHYL CELLULOSE; EUDRAGIT; GELATIN; HYDROXYPROPYLMETHYLCELLULOSE; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INFLIXIMAB; LACTULOSE; MESALAZINE; MORPHINE; OLSALAZINE; POLYMER; PREDNISOLONE; PROBIOTIC AGENT; PULLULAN; SHELLAC; STARCH; SULFAPYRIDINE; UNINDEXED DRUG; ANTIINFLAMMATORY AGENT; GASTROINTESTINAL AGENT; METHYLMETHACRYLATE METHACRYLIC ACID COPOLYMER; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; POLYMETHACRYLIC ACID DERIVATIVE;

AREA UNDER THE CURVE; CLINICAL TRIAL; COLON; CROHN DISEASE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; DRUG TOLERABILITY; ENTERITIS; ENTEROPATHY; GAMMA SCINTIGRAPHY; HUMAN; ILEUM; IN VITRO STUDY; IN VIVO STUDY; PH; PHYSICAL CHEMISTRY; REVIEW; SIDE EFFECT; STOMACH EMPTYING; SUSTAINED RELEASE FORMULATION; ULCERATIVE COLITIS; ANIMAL; ARTICLE; CHEMISTRY; METABOLISM; MICROCAPSULE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; SOLUBILITY; TIME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CAPSULES; CHEMISTRY, PHARMACEUTICAL; COLON; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL AGENTS; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATORY BOWEL DISEASES; POLYMETHACRYLIC ACIDS; SOLUBILITY; STARCH; TIME FACTORS;

EID: 12344250990     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.1.159     Document Type: Review

References (29)

1. In: British National Formulary. Number 48, Pharmaceutical Press and British Medical Association, London (2004).
2. KARP CK, TARGAN SR: Ulcerative colitis. Evidence for an updated hypothesis of disease pathogenesis. In: Mucosal Immunology. Ogra PL et al. (Eds.), 2nd edition, Academic Press, San Diego (1999):1047-1053.
3. DUCHMANN R, ZEITZ M: Crohn's disease. In: Mucosal Immunology. Ogra PL et al. (Eds.), 2nd edition, Academic Press, San Diego (1999):1055-1080.
4. COURTNEY MG: The medical treatment of ulcerative colitis. In: Ulcerative Colitis. O'Morain CA (Ed.), CRC Press, Boca Raton (1991):139-151.
5. LOFTUS EV: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology (2004) 126:1504-1517.
6. In: Martindale. Sweetman SC (Ed.), 33rd edition, Pharmaceutical Press, London (2002):1205-1206.
7. NAYAR M, RHODES JM: Management of inflammatory bowel disease. Postgrad. Med. J. (2004) 80:206-213.
8. WATTS PJ, ILLUM L: Colonic drug delivery. Drug Dev. Ind. Pharm. (1997) 23:893-913.
9. CHOURASIA MK, JAIN SK: Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharmaceut. Sci. (2003) 6:33-66.
10. YANG L, CHU JS, FIX JA. Colon-specific drug delivery: new approaches and in vitro/ in vivo evaluation. Int. J. Pharm. (2002) 235:1-15.
11. WILSON CG: Colonic drug delivery. In: Modified Release Drug Delivery Technology. Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):217-222.
12. MUKHERJI G, WILSON CG: Enteric coating for colonic delivery. In: Modified Release Drug Delivery Technology. Rathbone MJ. Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):223-232.
13. MUKHERJI G, WILSON CG: Biopolymers and colonic delivery. In: Modified Release Drug Delivery Technology. Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):233-242.
14. LEE WW, WILSON CG, MUKHERJI G: Time-dependent systems for colonic delivery. In: Modified Release Drug Delivery Technology. Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):243-248.
15. DAVIS SS, HARDY JG, FARA JW. Transit of pharmaceutical dosage forms through the small intestine. Gut (1986) 27:886-892.
16. MILOJEVIC S, NEWTON JM, CUMMINGS JH et al.: Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets. J. Control. Rel. (1996) 38 85-94.
17. KATSUMA M, WATANABE S, TAKEMURA S et al.: Scintigraphic evaluation of a novel colon-targeted delivery system (CODES™) in healthy volunteers. J. Pharm. Sci. (2004) 93:1287-1299.
18. STEVENS HNE: Pulsincap and hydrophilic sandwich (HS) capsules: Innovative time-delayed oral drug delivery technologies. In: Modified Release Drug Delivery Technology. Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York, (2003):257-262.
19. POZZI F, FURLANI P, GAZZANIGA A, DAVIS SS, WILDING IR. The TIME CLOCK system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control. Rel. (1994) 31:99-108.
20. GOLDBERG M, GOMEZ-ORELLANA I: Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov. (2003) 2 289-295.
21. SCHROEDER KW, TREMAINE WJ, ILSTRUP DL: Coated 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N. Engl. J. Med. (1987) 317:1625-1629.
22. VILIVALAM VD, ILLUM L, IQBAL K: Starch capsules: an alternative system for oral drug delivery. Pharm. Sci. Technol. Today (2000) 3:64-69.
23. AUGSBURGER L: Hard and soft shell capsules. In: Modern Pharmaceutics. Banker GS, Rhodes CT (Eds.), 3rd edition, Marcel Dekker, New York (1996):395-440.
24. HOWE D, GARRELL R, DANDREA L, IQBAL K: Development and evaluation of a hot melt formulation in enteric coated starch capsules. AAPS Pharm. Sci. (2001) 3(3).
25. Rowe RC, Shesky PJ, Weller PJ (Eds.): Handbook of Pharmaceutical Excipients. 4th Edition, Pharmaceutical Press, London(2003).
26. WILDING IR, COUPE AJ, DAVIS SS: The role of gamma-scintigraphy in oral drug delivery. Adv. Drug Deliv. Rev. (2001) 46:103-124.
27. SKALSKY B, RUDOLPH M, RENNER G: In-vivo evaluation of EUDRACOL™: a novel pH- and time-controlled multiple unit colonic drug delivery system. Transactions of Controlled Release Society 31st Annual Meeting (2004): Abstract 051.
28. WONG PSL, GUPTA SK, STEWART BE: Osmotically controlled tablets. In: Modified Release Drug Delivery Technology. Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):101-114.
29. PRIOR DVL, CONNOR AL, WILDING IR: The enterion capsule. In: Modified Release Drug Delivery Technology. Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):273-288.